CKPT logo

Checkpoint Therapeutics (CKPT)

Profile

Full Name

Checkpoint Therapeutics, Inc.

Ticker Symbol

CKPT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 19, 2016

Indexes

Not included

Website

http://checkpointtx.com

Employees

24

Key Details

Price

$4.01(+0.50%)

Market cap

$335.89M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$41.00K(-60.19% YoY)

Annual EPS

-$1.42(+55.21% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.01
CKPT price is $4.01

30-Day Relative Volume

0.96
CKPT 30-day relative volume is 0.96

Price Performance

Price Today change

+0.5%
CKPT price is up +0.5% today

Price YTD change

+25.31%
CKPT price is up +25.31% since January 1st

Price 1-year change

+125.28%
CKPT price is up +125.28% year-on-year

Price 3-year change

-72.15%
CKPT price is down -72.15% over the past 3 years

Price Range

Price All-time high

$150.00
CKPT price is currently -97.33% below its historical high of $150.00

Price 3-year low

$1.30
CKPT price is currently +208.46% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$335.89M
CKPT market capitalization is $335.89 million

Market cap 3-year change

+156.89%
CKPT market capitalization is up +156.89% over the past 3 years

Market cap All-time high

$373.63M
CKPT market capitalization is currently -10.10% below its historical high of $373.63 million

Market cap sector rank

64.34%
CKPT market capitalization is higher than 64.34% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+134.72%
CKPT shares outstanding is up +134.72% year-on-year

Shares Outstanding 3-Year Change

+822.5%
CKPT shares outstanding is up +822.5% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.21
CKPT beta is 0.21

200-day SMA

$3.03
CKPT price is currently +32.15% above its 200-day simple moving average

50-day SMA

$3.52
CKPT price is currently +13.78% above its 50-day simple moving average

RSI

60.71
CKPT 14-day relative strength index is 60.71

Volume

0.96
CKPT 30-day relative volume is 0.96

ATR

$0.06
CKPT average true range is $0.06

10-day Historical Volatility

9.42%
CKPT 10-day historical volatility is 9.42%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$41.00K
CKPT annual revenue is $41.00 thousand

Revenue Analysts estimate

$72.83M
CKPT annual revenue is currently -99.94% lower than the consensus analysts' forecast

Revenue 1-year change

-60.19%
CKPT annual revenue is down -60.19% year-on-year

Revenue Sector rank

3.81%
CKPT annual revenue is higher than 3.81% of companies in Healthcare sector

EPS

EPS

-$1.42
CKPT annual earnings per share is -$1.42

EPS Analysts estimate

$0.27
CKPT annual earnings per share is currently -625.93% lower than the consensus analysts' forecast

EPS 1-year change

+55.21%
CKPT annual earnings per share is up +55.21% year-on-year

EPS Sector rank

47.48%
CKPT annual earnings per share is higher than 47.48% of companies in Healthcare sector

Profit

Gross profit

-
CKPT annual gross profit value is unknown

Gross margin

-
CKPT annual gross profit margin value is unknown

Operating profit

-$56.17M
CKPT annual operating income is -$56.17 million

Operating margin

-137.01K%
CKPT annual operating profit margin is -137.01 thousand%

Net income

-$56.24M
CKPT annual net profit is -$56.24 million

Net margin

-137.17K%
CKPT annual net profit margin is -137.17 thousand%

Expenses

Total expenses

$56.22M
CKPT annual total expenses is $56.22 million

Operating expenses

$56.22M
CKPT annual total operating expenses is $56.22 million

Cost of goods sold

-
CKPT annual cost of goods sold value is unknown

Selling, general & administrative expenses

$20.06M
CKPT annual SGA is $20.06 million

Depreciation and amortization

-
CKPT annual depreciation & amortization value is unknown

Interest expense

-
CKPT annual interest expense value is unknown

Income tax

-
CKPT annual income tax value is unknown

EBIT & EBITDA

EBIT

-$56.17M
CKPT annual earnings before interest & taxes is -$56.17 million

EBITDA

-$56.17M
CKPT annual EBITDA is -$56.17 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$7.47M
CKPT annual total assets is $7.47 million

Non current assets

$0.00
CKPT annual long term assets is $0.00

Current assets

$7.47M
CKPT annual total current assets is $7.47 million

Cash and cash equivalents

$6.60M
CKPT annual cash & cash equivalents is $6.60 million

Accounts receivable

-
CKPT annual accounts receivable value is unknown

Inventory

-
CKPT annual inventory value is unknown

Liabilities

Total liabilities

$20.10M
CKPT annual total liabilities is $20.10 million

Long term liabilities

$0.00
CKPT annual total long term liabilities is $0.00

Current liabilities

$20.10M
CKPT annual total current liabilities is $20.10 million

Accounts payable

$6.09M
CKPT annual accounts payable is $6.09 million

Debt

Total debt

$0.00
CKPT annual total debt is $0.00

Total debt 1-year change

0%
CKPT {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
CKPT annual long term debt value is unknown

Short term debt

-
CKPT annual short term debt value is unknown

Equity & Capital

Shareholders equity

-$12.63M
CKPT annual stockholders equity is -$12.63 million

Book value

-$12.63M
CKPT annual book value is -$12.63 million

Retained earnings

-$370.57M
CKPT annual retained earnings is -$370.57 million

Working capital

-$12.63M
CKPT annual working capital is -$12.63 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$31.10M
CKPT annual cash flow from operations is -$31.10 million

Cash from operations 1-year change

+34.65%
CKPT annual cash flow from operations is up +34.65% year-on-year

Cash from investing

-
CKPT annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
CKPT annual cash flow from investing activities 1-year change is unknown

Cash from financing

$32.78M
CKPT annual cash flow from financing activities is $32.78 million

Cash from financing 1-year change

-18.97%
CKPT annual cash flow from financing activities is down -18.97% year-on-year

CAPEX

CAPEX

-
CKPT annual capital expenditures value is unknown

CAPEX 1-year change

-
CKPT annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$31.10M
CKPT annual free cash flow is -$31.10 million

Free cash flow 1-year change

+34.65%
CKPT annual free cash flow is up +34.65% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CKPT annual gross profit margin value is unknown

Operating margin

-137.01K%
CKPT annual operating profit margin is -137.01 thousand%

Net margin

-137.17K%
CKPT annual net profit margin is -137.17 thousand%

ROA & ROE

ROA

-875.40%
CKPT annual return on assets is -875.40%

ROE

445.47%
CKPT annual return on equity is 445.47%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CKPT price to earnings ratio value is unknown

PE ratio Sector rank

-
CKPT price to earnings ratio is unknown

PB Ratio

PB ratio

-26.61
CKPT price to book ratio is -26.61

PB ratio Sector rank

1.23%
CKPT price to book ratio is higher than 1.23% of companies in Healthcare sector

PS Ratio

PS ratio

-
CKPT price to sales ratio value is unknown

PS ratio Sector rank

-
CKPT price to sales ratio is unknown

Enterprise value

Enterprise value

$329.29M
CKPT enterprise value is $329.29 million

Enterprise value Sector rank

64.66%
CKPT enterprise value is higher than 64.66% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-5.86
CKPT EV/EBITDA is -5.86

EV/EBITDA Sector rank

16.42%
CKPT EV/EBITDA is higher than 16.42% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.37
CKPT annual current ratio is 0.37

Quick ratio

-
CKPT annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CKPT annual debt to equity ratio is 0.00

Interest coverage ratio

-
CKPT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CKPT piotroski f-score value is unknown

Altman Z-Score

-86.25
CKPT altman z-score is -86.25

Analyst ratings

Recent major analysts updates

Mar 31, 25 D. Boral Capital
Buy
Mar 11, 25 HC Wainwright & Co.
Neutral
Mar 10, 25 Lake Street
Hold
Mar 10, 25 D. Boral Capital
Buy
Jan 13, 25 D. Boral Capital
Buy
Dec 16, 24 Lake Street
Buy
Dec 16, 24 HC Wainwright & Co.
Buy
Dec 4, 24 HC Wainwright & Co.
Buy
Nov 14, 24 HC Wainwright & Co.
Buy
Aug 12, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ETON logo
Eton Pharmaceuticals (ETON)
Maze Therapeutics (MAZE)
TRML logo
Tourmaline Bio (TRML)
Rapport Therapeutics (RAPP)
NPCE logo
NeuroPace (NPCE)
MPLN logo
MultiPlan (MPLN)
Claritev (CTEV)
ALT logo
Altimmune (ALT)
PHAT logo
Phathom Pharmaceuticals (PHAT)
  • What is the ticker symbol for Checkpoint Therapeutics?
  • Does Checkpoint Therapeutics pay dividends?
  • What sector is Checkpoint Therapeutics in?
  • What industry is Checkpoint Therapeutics in?
  • What country is Checkpoint Therapeutics based in?
  • When did Checkpoint Therapeutics go public?
  • Is Checkpoint Therapeutics in the S&P 500?
  • Is Checkpoint Therapeutics in the NASDAQ 100?
  • Is Checkpoint Therapeutics in the Dow Jones?
  • When was Checkpoint Therapeutics's last earnings report?
  • When does Checkpoint Therapeutics report earnings?
  • Should I buy Checkpoint Therapeutics stock now?

What is the ticker symbol for Checkpoint Therapeutics?

The ticker symbol for Checkpoint Therapeutics is NASDAQ:CKPT

Does Checkpoint Therapeutics pay dividends?

No, Checkpoint Therapeutics does not pay dividends

What sector is Checkpoint Therapeutics in?

Checkpoint Therapeutics is in the Healthcare sector

What industry is Checkpoint Therapeutics in?

Checkpoint Therapeutics is in the Biotechnology industry

What country is Checkpoint Therapeutics based in?

Checkpoint Therapeutics is headquartered in United States

When did Checkpoint Therapeutics go public?

Checkpoint Therapeutics's initial public offering (IPO) was on December 19, 2016

Is Checkpoint Therapeutics in the S&P 500?

No, Checkpoint Therapeutics is not included in the S&P 500 index

Is Checkpoint Therapeutics in the NASDAQ 100?

No, Checkpoint Therapeutics is not included in the NASDAQ 100 index

Is Checkpoint Therapeutics in the Dow Jones?

No, Checkpoint Therapeutics is not included in the Dow Jones index

When was Checkpoint Therapeutics's last earnings report?

Checkpoint Therapeutics's most recent earnings report was on Mar 28, 2025

When does Checkpoint Therapeutics report earnings?

The next expected earnings date for Checkpoint Therapeutics is May 9, 2025

Should I buy Checkpoint Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page